Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PXS-5505 |
Trade Name | |
Synonyms | PXS 5505|PXS5505 |
Drug Descriptions |
PXS-5505 inhibits lysyl oxidases, potentially leading to reduced tumor growth (HPB (2021) 23: S493-S494). |
DrugClasses | |
CAS Registry Number | 2409963-83-1 |
NCIT ID | C179584 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + Bevacizumab + PXS-5505 | Atezolizumab Bevacizumab PXS-5505 | 0 | 1 |
PXS-5505 | PXS-5505 | 0 | 1 |